메뉴 건너뛰기




Volumn 54, Issue 1, 2002, Pages 11-20

Serotonergic modulating drugs for functional gastrointestinal diseases

Author keywords

Drugs; Functional gastrointestinal disease; Serotonin

Indexed keywords

ALOSETRON; BUSPIRONE; CILANSETRON; CISAPRIDE; CISPLATIN; GRANISETRON; ONDANSETRON; PRUCALOPRIDE; SEROTONIN 1 AGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SULPIRIDE; SUMATRIPTAN; TEGASEROD;

EID: 0036968217     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01612.x     Document Type: Review
Times cited : (56)

References (89)
  • 1
    • 0002716935 scopus 로고
    • Thee release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa
    • Bulbring E, Crema A. Thee release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J Physiol (Lond.) 1959; 146: 18-28.
    • (1959) J Physiol (Lond.) , vol.146 , pp. 18-28
    • Bulbring, E.1    Crema, A.2
  • 2
    • 0018140823 scopus 로고
    • Fine structural classification and comparative distribution of endocrine cells in normal human large intestine
    • Cristina ML, Lehy T, Zeitoun P, Dufougeray F. Fine structural classification and comparative distribution of endocrine cells in normal human large intestine. Gastroenterology 1978; 75: 20-28.
    • (1978) Gastroenterology , vol.75 , pp. 20-28
    • Cristina, M.L.1    Lehy, T.2    Zeitoun, P.3    Dufougeray, F.4
  • 3
    • 0020501561 scopus 로고
    • Endocrine cells in human intestine: An immunocytochemical study
    • Sjolund K, Sanden G, Hakanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983; 85: 1120-1130.
    • (1983) Gastroenterology , vol.85 , pp. 1120-1130
    • Sjolund, K.1    Sanden, G.2    Hakanson, R.3    Sundler, F.4
  • 4
    • 0025744281 scopus 로고
    • Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: Involvement of 5-HT3 receptors
    • Schworer H, Racke K, Kilbinger H. Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: involvement of 5-HT3 receptors. Naunyn Schmiedebergs Arch Pharmacol 1991; 344: 143-149.
    • (1991) Naunyn Schmiedebergs Arch Pharmacol , vol.344 , pp. 143-149
    • Schworer, H.1    Racke, K.2    Kilbinger, H.3
  • 5
    • 0022461509 scopus 로고
    • Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors
    • Richter G, Stockmann F, Conlon JM, Creutzfeldt W. Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors. Gastroenterology 1986; 91: 612-618.
    • (1986) Gastroenterology , vol.91 , pp. 612-618
    • Richter, G.1    Stockmann, F.2    Conlon, J.M.3    Creutzfeldt, W.4
  • 6
    • 0028183017 scopus 로고
    • International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)
    • Hoyer D, Clarke DE, Fozard JR, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46: 157-203.
    • (1994) Pharmacol Rev , vol.46 , pp. 157-203
    • Hoyer, D.1    Clarke, D.E.2    Fozard, J.R.3
  • 7
    • 0027488084 scopus 로고
    • Effects of 5-hydroxytryptamine (5-HT) on the discharge of vagal mechanoreceptors and motility in the upper gastrointestinal tract of the ferret
    • Blackshaw LA, Grundy D. Effects of 5-hydroxytryptamine (5-HT) on the discharge of vagal mechanoreceptors and motility in the upper gastrointestinal tract of the ferret. J Auton Nerv Syst 1993; 45: 51-59.
    • (1993) J Auton Nerv Syst , vol.45 , pp. 51-59
    • Blackshaw, L.A.1    Grundy, D.2
  • 9
    • 0026643829 scopus 로고
    • Changes in serotonin metabolism in cancer patients. Its relationship to nausea and vomiting induced by chemotherapeutic drugs
    • Cubeddu LX, Hoffmann IS, Fuenmayor NT, Malave JJ. Changes in serotonin metabolism in cancer patients. Its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br J Cancer 1992; 66: 198-203.
    • (1992) Br J Cancer , vol.66 , pp. 198-203
    • Cubeddu, L.X.1    Hoffmann, I.S.2    Fuenmayor, N.T.3    Malave, J.J.4
  • 10
    • 0026513238 scopus 로고
    • Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: Activity-induced expression of Fos immunoreactivity
    • Kirchgessner AL, Tamir H, Gershon MD. Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J Neurosci 1992; 12: 235-248.
    • (1992) J Neurosci , vol.12 , pp. 235-248
    • Kirchgessner, A.L.1    Tamir, H.2    Gershon, M.D.3
  • 11
    • 0031836108 scopus 로고    scopus 로고
    • Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans
    • Lordal M, Wallen H, Hjemdahl P, Beck O, Hellstrom PM. Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans. Clin Sci (Colch) 1998; 94: 663-670.
    • (1998) Clin Sci (Colch) , vol.94 , pp. 663-670
    • Lordal, M.1    Wallen, H.2    Hjemdahl, P.3    Beck, O.4    Hellstrom, P.M.5
  • 12
    • 0028301413 scopus 로고
    • Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome
    • Gorard DA, Libby GW, Farthing MJ. Influence of antidepressants on whole gut and orocaecal transit times in health and irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 159-166.
    • (1994) Aliment Pharmacol Ther , vol.8 , pp. 159-166
    • Gorard, D.A.1    Libby, G.W.2    Farthing, M.J.3
  • 14
    • 0033005212 scopus 로고    scopus 로고
    • Serotonin stimulates migrating myoelectric complex via 5-HT3-receptors dependent on cholinergic pathways in rat small intestine
    • Lordal M, Hellstrom PM. Serotonin stimulates migrating myoelectric complex via 5-HT3-receptors dependent on cholinergic pathways in rat small intestine. Neurogastroenterol Motil 1999; 11: 1-10.
    • (1999) Neurogastroenterol Motil , vol.11 , pp. 1-10
    • Lordal, M.1    Hellstrom, P.M.2
  • 15
    • 4243300063 scopus 로고    scopus 로고
    • MKC-733, a selective 5-HT3 receptor agonist stimulates fasting human antral motility
    • Coleman NS, Wright J, Parker M, Spiller RC. MKC-733, a selective 5-HT3 receptor agonist stimulates fasting human antral motility. Gastroenterology 2001; 120: A460-A461.
    • (2001) Gastroenterology , vol.120
    • Coleman, N.S.1    Wright, J.2    Parker, M.3    Spiller, R.C.4
  • 17
    • 0027305518 scopus 로고
    • 5-hydroxytryptamine-3 receptors are involved in the initiation of gastric phase-3 motor activity in humans
    • Wilmer A, Tack J, Coremans G, Janssens J, Peeters T, Vantrappen G. 5-hydroxytryptamine-3 receptors are involved in the initiation of gastric phase-3 motor activity in humans. Gastroenterology 1993; 105: 773-780.
    • (1993) Gastroenterology , vol.105 , pp. 773-780
    • Wilmer, A.1    Tack, J.2    Coremans, G.3    Janssens, J.4    Peeters, T.5    Vantrappen, G.6
  • 18
    • 0025753446 scopus 로고
    • Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog
    • Itoh Z, Mizumoto A, Iwanaga Y, Yoshida N, Torii K, Wakabayashi K. Involvement of 5-hydroxytryptamine 3 receptors in regulation of interdigestive gastric contractions by motilin in the dog. Gastroenterology 1991; 100: 901-908.
    • (1991) Gastroenterology , vol.100 , pp. 901-908
    • Itoh, Z.1    Mizumoto, A.2    Iwanaga, Y.3    Yoshida, N.4    Torii, K.5    Wakabayashi, K.6
  • 20
    • 0026418189 scopus 로고
    • Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid
    • Desai KM, Sessa WC, Vane JR. Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid. Nature 1991; 351: 477-479.
    • (1991) Nature , vol.351 , pp. 477-479
    • Desai, K.M.1    Sessa, W.C.2    Vane, J.R.3
  • 21
    • 0034070874 scopus 로고    scopus 로고
    • Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man
    • Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000; 46: 468-473.
    • (2000) Gut , vol.46 , pp. 468-473
    • Tack, J.1    Coulie, B.2    Wilmer, A.3    Andrioli, A.4    Janssens, J.5
  • 22
    • 0029859119 scopus 로고    scopus 로고
    • Gastric antisecretory effect of serotonin: Quantitation of release and site of action
    • Lepard KJ, Chi J, Mohammed JR, Gidener S, Stephens RL Jr. Gastric antisecretory effect of serotonin: quantitation of release and site of action. Am J Physiol 1996; 271: E669-E677.
    • (1996) Am J Physiol , vol.271
    • Lepard, K.J.1    Chi, J.2    Mohammed, J.R.3    Gidener, S.4    Stephens R.L., Jr.5
  • 23
    • 0025895099 scopus 로고
    • BRL 24924, a 5-hydroxytryptamine type 3 antagonist, and gastric secretion of acid and pepsin in vivo
    • Johansen B, Bech K. BRL 24924, a 5-hydroxytryptamine type 3 antagonist, and gastric secretion of acid and pepsin in vivo. Digestion 1991; 48: 121-127.
    • (1991) Digestion , vol.48 , pp. 121-127
    • Johansen, B.1    Bech, K.2
  • 24
    • 0029830522 scopus 로고    scopus 로고
    • Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine
    • Foxx-Orenstein AE, Kuemmerle JF, Grider JR. Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology 1996; 111: 1281-1290.
    • (1996) Gastroenterology , vol.111 , pp. 1281-1290
    • Foxx-Orenstein, A.E.1    Kuemmerle, J.F.2    Grider, J.R.3
  • 25
    • 0031595212 scopus 로고    scopus 로고
    • 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine
    • Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998; 115: 370-380.
    • (1998) Gastroenterology , vol.115 , pp. 370-380
    • Grider, J.R.1    Foxx-Orenstein, A.E.2    Jin, J.G.3
  • 26
    • 0029976793 scopus 로고    scopus 로고
    • 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons
    • Grider JR, Kuemmerle JF, Jin JG. 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons. Am J Physiol 1996; 270: G778-G782.
    • (1996) Am J Physiol , vol.270
    • Grider, J.R.1    Kuemmerle, J.F.2    Jin, J.G.3
  • 27
    • 0030278350 scopus 로고    scopus 로고
    • Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon
    • Kadowaki M, Wade PR, Gershon MD. Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon. Am J Physiol 1996; 271: G849-G857.
    • (1996) Am J Physiol , vol.271
    • Kadowaki, M.1    Wade, P.R.2    Gershon, M.D.3
  • 28
    • 0033939079 scopus 로고    scopus 로고
    • The inhibition of cholera toxin-induced 5-HT release by the 5-HT (3) receptor antagonist, granisetron, in the rat
    • In Process Citation
    • Turvill JL, Connor P, Farthing MJ. The inhibition of cholera toxin-induced 5-HT release by the 5-HT (3) receptor antagonist, granisetron, in the rat [In Process Citation]. Br J Pharmacol 2000; 130: 1031-1036.
    • (2000) Br J Pharmacol , vol.130 , pp. 1031-1036
    • Turvill, J.L.1    Connor, P.2    Farthing, M.J.3
  • 29
    • 0033850197 scopus 로고    scopus 로고
    • Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins
    • Mourad FH, Nassar CF. Effect of vasoactive intestinal polypeptide (VIP) antagonism on rat jejunal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Gut 2000; 47: 382-386.
    • (2000) Gut , vol.47 , pp. 382-386
    • Mourad, F.H.1    Nassar, C.F.2
  • 30
    • 0031563282 scopus 로고    scopus 로고
    • Activation of 5-HT1P receptors on submucosal afferents subsequently triggers VIP neurons and chloride secretion in the guinea-pig colon
    • Cooke HJ, Sidhu M, Wang YZ. Activation of 5-HT1P receptors on submucosal afferents subsequently triggers VIP neurons and chloride secretion in the guinea-pig colon. J Auton Nerv Syst 1997; 66: 105-110.
    • (1997) J Auton Nerv Syst , vol.66 , pp. 105-110
    • Cooke, H.J.1    Sidhu, M.2    Wang, Y.Z.3
  • 31
    • 0033862394 scopus 로고    scopus 로고
    • Nitric oxide is a neurotransmitter in the chloride secretory response to serotonin in rat colon
    • Stoner MC, Scherr AM, Lee JA, Wolfe LG, Kellum JM. Nitric oxide is a neurotransmitter in the chloride secretory response to serotonin in rat colon. Surgery 2000; 128: 240-245.
    • (2000) Surgery , vol.128 , pp. 240-245
    • Stoner, M.C.1    Scherr, A.M.2    Lee, J.A.3    Wolfe, L.G.4    Kellum, J.M.5
  • 32
    • 0024586843 scopus 로고
    • Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo
    • Beubler E, Kollar G, Saria A, Bukhave K, Rask-Madsen J. Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology 1989; 96: 368-376.
    • (1989) Gastroenterology , vol.96 , pp. 368-376
    • Beubler, E.1    Kollar, G.2    Saria, A.3    Bukhave, K.4    Rask-Madsen, J.5
  • 33
    • 0030833013 scopus 로고    scopus 로고
    • In vivo effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: A segmental perfusion study
    • Bearcroft CP, Andre EA, Farthing MJ. In vivo effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: a segmental perfusion study. Aliment Pharmacol Ther 1997; 11: 1109-1114.
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 1109-1114
    • Bearcroft, C.P.1    Andre, E.A.2    Farthing, M.J.3
  • 34
    • 0030600410 scopus 로고    scopus 로고
    • The role of the 5-HT4 receptor in Cl-secretion in human jejunal mucosa
    • Budhoo MR, Harris RP, Kellum JM. The role of the 5-HT4 receptor in Cl-secretion in human jejunal mucosa. Eur J Pharmacol 1996; 314: 109-114.
    • (1996) Eur J Pharmacol , vol.314 , pp. 109-114
    • Budhoo, M.R.1    Harris, R.P.2    Kellum, J.M.3
  • 35
    • 0027131630 scopus 로고
    • Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT
    • Borman RA, Burleigh DE. Evidence for the involvement of a 5-HT4 receptor in the secretory response of human small intestine to 5-HT. Br J Pharmacol 1993; 110: 927-928.
    • (1993) Br J Pharmacol , vol.110 , pp. 927-928
    • Borman, R.A.1    Burleigh, D.E.2
  • 36
    • 0027469647 scopus 로고
    • Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome
    • Prior A, Read NW. Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 175-180.
    • (1993) Aliment Pharmacol Ther , vol.7 , pp. 175-180
    • Prior, A.1    Read, N.W.2
  • 37
    • 0032159413 scopus 로고    scopus 로고
    • Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex
    • Bjornsson ES, Chey WD, Ladabaum U, et al. Differential 5-HT3 mediation of human gastrocolonic response and colonic peristaltic reflex. Am J Physiol 1998; 275: G498-G505.
    • (1998) Am J Physiol , vol.275
    • Bjornsson, E.S.1    Chey, W.D.2    Ladabaum, U.3
  • 38
    • 0024999306 scopus 로고
    • Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist
    • Gore S, Gilmore IT, Haigh CG, Brownless SM, Stockdale H, Morris AI. Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther 1990; 4: 139-144.
    • (1990) Aliment Pharmacol Ther , vol.4 , pp. 139-144
    • Gore, S.1    Gilmore, I.T.2    Haigh, C.G.3    Brownless, S.M.4    Stockdale, H.5    Morris, A.I.6
  • 39
    • 0025219706 scopus 로고
    • GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man
    • Talley NJ, Phillips SF, Haddad A, et al. GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man. Digestive Dis Sci 1990; 35: 477-480.
    • (1990) Digestive Dis Sci , vol.35 , pp. 477-480
    • Talley, N.J.1    Phillips, S.F.2    Haddad, A.3
  • 40
    • 0028182404 scopus 로고
    • A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea
    • von O, Camilleri M, Kvols LK. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology 1994; 106: 1184-1189.
    • (1994) Gastroenterology , vol.106 , pp. 1184-1189
    • Von, O.1    Camilleri, M.2    Kvols, L.K.3
  • 42
    • 0031658491 scopus 로고    scopus 로고
    • Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome
    • Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1998; 12: 849-855.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 849-855
    • Delvaux, M.1    Louvel, D.2    Mamet, J.P.3    Campos-Oriola, R.4    Frexinos, J.5
  • 43
    • 0032589966 scopus 로고    scopus 로고
    • Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers
    • Poen AC, Felt-Bersma RJ, Van Dongen PA, Meuwissen SG. Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers. Aliment Pharmacol Ther 1999; 13: 1493-1497.
    • (1999) Aliment Pharmacol Ther , vol.13 , pp. 1493-1497
    • Poen, A.C.1    Felt-Bersma, R.J.2    Van Dongen, P.A.3    Meuwissen, S.G.4
  • 44
    • 0033005188 scopus 로고    scopus 로고
    • Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans
    • Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut 1999; 44: 682-686.
    • (1999) Gut , vol.44 , pp. 682-686
    • Bouras, E.P.1    Camilleri, M.2    Burton, D.D.3    McKinzie, S.4
  • 45
    • 0001030304 scopus 로고    scopus 로고
    • The 5-HT4 receptor partial agonist tegaserod (HTF919) accelerates upper and lower gastrointestinal (GI) transit
    • Degen L, Matzinger D, Merz M, et al. The 5-HT4 receptor partial agonist tegaserod (HTF919) accelerates upper and lower gastrointestinal (GI) transit. Gastroenterology 2000; 118: A845.
    • (2000) Gastroenterology , vol.118
    • Degen, L.1    Matzinger, D.2    Merz, M.3
  • 46
    • 0343145638 scopus 로고    scopus 로고
    • Post-synaptic 5-HT4 receptor modulation of tachykinergic excitation of rat oesophageal tunica muscularis mucosae
    • Goldhill J, Porquet MF, Angel I. Post-synaptic 5-HT4 receptor modulation of tachykinergic excitation of rat oesophageal tunica muscularis mucosae. Eur J Pharmacol 1997; 323: 229-233.
    • (1997) Eur J Pharmacol , vol.323 , pp. 229-233
    • Goldhill, J.1    Porquet, M.F.2    Angel, I.3
  • 47
    • 0024511561 scopus 로고
    • Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum
    • Tonini M, Galligan JJ, North RA. Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea pig ileum. Gastroenterology 1989; 96: 1257-1264.
    • (1989) Gastroenterology , vol.96 , pp. 1257-1264
    • Tonini, M.1    Galligan, J.J.2    North, R.A.3
  • 49
    • 0029862629 scopus 로고    scopus 로고
    • Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia
    • Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-1042.
    • (1996) Gastroenterology , vol.110 , pp. 1036-1042
    • Stanghellini, V.1    Tosetti, C.2    Paternico, A.3
  • 50
    • 0031731346 scopus 로고    scopus 로고
    • Role of impaired gastric accommodation to a meal in functional dyspepsia
    • Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia [see comments]. Gastroenterology 1998; 115: 1346-1352.
    • (1998) Gastroenterology , vol.115 , pp. 1346-1352
    • Tack, J.1    Piessevaux, H.2    Coulie, B.3    Caenepeel, P.4    Janssens, J.5
  • 51
    • 0033003317 scopus 로고    scopus 로고
    • Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function
    • Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999; 44: 55-64.
    • (1999) Gut , vol.44 , pp. 55-64
    • Thumshirn, M.1    Camilleri, M.2    Saslow, S.B.3    Williams, D.E.4    Burton, D.D.5    Hanson, R.B.6
  • 52
    • 0025128853 scopus 로고
    • Bacteriotherapy for Clostridium difficile diarrhoea
    • Tvede M, RaskMadsen J. Bacteriotherapy for Clostridium difficile diarrhoea. Lancet 1990; 335: 110.
    • (1990) Lancet , vol.335 , pp. 110
    • Tvede, M.1    RaskMadsen, J.2
  • 53
    • 0031876343 scopus 로고    scopus 로고
    • The influence of cisapride on gastric tone and the perception of gastric distension
    • Tack J, Broeckaert D, Coulie B, Janssens J. The influence of cisapride on gastric tone and the perception of gastric distension. Aliment Pharmacol Ther 1998; 12: 761-766.
    • (1998) Aliment Pharmacol Ther , vol.12 , pp. 761-766
    • Tack, J.1    Broeckaert, D.2    Coulie, B.3    Janssens, J.4
  • 54
    • 0031022678 scopus 로고    scopus 로고
    • Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study
    • de Groot GH, de Both PS. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. Aliment Pharmacol Ther 1997; 11: 193-199.
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 193-199
    • De Groot, G.H.1    De Both, P.S.2
  • 55
    • 0028952152 scopus 로고
    • Efficacy of cisapride therapy in functional dyspepsia
    • Kellow JE, Cowan H, Shuter B, et al. Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995; 9: 153-160.
    • (1995) Aliment Pharmacol Ther , vol.9 , pp. 153-160
    • Kellow, J.E.1    Cowan, H.2    Shuter, B.3
  • 56
    • 0032421118 scopus 로고    scopus 로고
    • The effect of cisapride on dysmotility-like functional dyspepsia: Reduction of the fasting and postprandial area, but not of the postprandial antral expansion
    • Eberl T, Barnert J, Dumitrascu DL, Fischer J, Wienbeck M. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion. Eur J Gastroenterol Hepatol 1998; 10: 991-995.
    • (1998) Eur J Gastroenterol Hepatol , vol.10 , pp. 991-995
    • Eberl, T.1    Barnert, J.2    Dumitrascu, D.L.3    Fischer, J.4    Wienbeck, M.5
  • 58
    • 0034051862 scopus 로고    scopus 로고
    • Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis
    • Mansi C, Borro P, Giacomini M, et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000; 14: 561-569.
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 561-569
    • Mansi, C.1    Borro, P.2    Giacomini, M.3
  • 59
    • 0001542218 scopus 로고    scopus 로고
    • Functional dyspepsia. Impaired fundic accommodation
    • Tack J. Functional dyspepsia. Impaired fundic accommodation. Curr Treat Options Gastroenterol 2000; 3: 287-294.
    • (2000) Curr Treat Options Gastroenterol , vol.3 , pp. 287-294
    • Tack, J.1
  • 60
    • 0032872312 scopus 로고    scopus 로고
    • Serotonin receptor physiology: Relation to emesis
    • Hasler WL. Serotonin receptor physiology: relation to emesis. Dig Dis Sci 1999; 44: 108S-13S.
    • (1999) Dig Dis Sci , vol.44
    • Hasler, W.L.1
  • 61
    • 0031024055 scopus 로고    scopus 로고
    • Antiemetic activity of ondansetron in acute gastroenteritis
    • Cubeddu LX, Trujillo LM, Talmaciu I, et al. Antiemetic activity of ondansetron in acute gastroenteritis. Aliment Pharmacol Ther 1997; 11: 185-191.
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 185-191
    • Cubeddu, L.X.1    Trujillo, L.M.2    Talmaciu, I.3
  • 62
    • 0032694283 scopus 로고    scopus 로고
    • Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples
    • Ragnarsson G, Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples. Scand J Gastroenterol 1999; 34: 993-1000.
    • (1999) Scand J Gastroenterol , vol.34 , pp. 993-1000
    • Ragnarsson, G.1    Bodemar, G.2
  • 63
    • 0031777140 scopus 로고    scopus 로고
    • Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study
    • Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998; 10: 415-421.
    • (1998) Eur J Gastroenterol Hepatol , vol.10 , pp. 415-421
    • Ragnarsson, G.1    Bodemar, G.2
  • 64
    • 0029848204 scopus 로고    scopus 로고
    • Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron)
    • Goldberg PA, Kamm MA, Setti-Carraro P, Van den Sijp JR, Roth C. Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron). Digestion 1996; 57: 478-483.
    • (1996) Digestion , vol.57 , pp. 478-483
    • Goldberg, P.A.1    Kamm, M.A.2    Setti-Carraro, P.3    Van den Sijp, J.R.4    Roth, C.5
  • 65
    • 0026741853 scopus 로고
    • Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: A pilot study
    • Steadman CJ, Talley NJ, Phillips SF, Zinsmeister AR. Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: A pilot study. Mayo Clinic Proceedings 1992; 67: 732-738.
    • (1992) Mayo Clinic Proceedings , vol.67 , pp. 732-738
    • Steadman, C.J.1    Talley, N.J.2    Phillips, S.F.3    Zinsmeister, A.R.4
  • 66
    • 0033625752 scopus 로고    scopus 로고
    • Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers
    • Houghton LA, Foster JM, Whorwell PJ. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther 2000; 14: 775-782.
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 775-782
    • Houghton, L.A.1    Foster, J.M.2    Whorwell, P.J.3
  • 67
    • 0003124927 scopus 로고    scopus 로고
    • Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome (DI-IBS)
    • Viramontes B, McKinzie S, Pardi DS, Burton D, Thomforde GM, Camilleri M. Alosetron retards small bowel and overall colonic transit in diarrhea-predominant irritable bowel syndrome (DI-IBS). Gastroenterology 2000; 118: A848.
    • (2000) Gastroenterology , vol.118
    • Viramontes, B.1    McKinzie, S.2    Pardi, D.S.3    Burton, D.4    Thomforde, G.M.5    Camilleri, M.6
  • 68
    • 0033963225 scopus 로고    scopus 로고
    • A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome
    • Bardhan KD, Bodemar G, Geldof H, Schutz E, Heath A, Mills JG, et al. A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2000; 14: 23-34.
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 23-34
    • Bardhan, K.D.1    Bodemar, G.2    Geldof, H.3    Schutz, E.4    Heath, A.5    Mills, J.G.6
  • 69
    • 0032848856 scopus 로고    scopus 로고
    • Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist
    • Camilleri M, Mayer EA, Drossman DA, et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999; 13: 1149-1159.
    • (1999) Aliment Pharmacol Ther , vol.13 , pp. 1149-1159
    • Camilleri, M.1    Mayer, E.A.2    Drossman, D.A.3
  • 70
    • 0034712539 scopus 로고    scopus 로고
    • Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial
    • Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial [see comments]. Lancet 2000; 355: 1035-1040.
    • (2000) Lancet , vol.355 , pp. 1035-1040
    • Camilleri, M.1    Northcutt, A.R.2    Kong, S.3    Dukes, G.E.4    McSorley, D.5    Mangel, A.W.6
  • 71
  • 72
    • 0032749795 scopus 로고    scopus 로고
    • Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients
    • Jones RH, Holtmann G, Rodrigo L, et al. Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients. Aliment Pharmacol Ther 1999; 13: 1419-1427.
    • (1999) Aliment Pharmacol Ther , vol.13 , pp. 1419-1427
    • Jones, R.H.1    Holtmann, G.2    Rodrigo, L.3
  • 73
    • 0033755876 scopus 로고    scopus 로고
    • Effects of a serotonin 5-HT (4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans
    • In Process Citation
    • Bharucha AE, Camilleri M, Haydock S, et al. Effects of a serotonin 5-HT (4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans [In Process Citation]. Gut 2000; 47: 667-674.
    • (2000) Gut , vol.47 , pp. 667-674
    • Bharucha, A.E.1    Camilleri, M.2    Haydock, S.3
  • 74
    • 0023073699 scopus 로고
    • Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects
    • Edwards CA, Holden S, Brown C, Read NW. Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects. Gut 1987; 28: 13-16.
    • (1987) Gut , vol.28 , pp. 13-16
    • Edwards, C.A.1    Holden, S.2    Brown, C.3    Read, N.W.4
  • 75
    • 0023220564 scopus 로고
    • Treatment of chronic constipation with cisapride and placebo
    • Muller-Lissner SA. Treatment of chronic constipation with cisapride and placebo. Gut 1987; 28: 1033-1038.
    • (1987) Gut , vol.28 , pp. 1033-1038
    • Muller-Lissner, S.A.1
  • 76
    • 0026015978 scopus 로고
    • 'Prokinetic' treatment of constipation-predominant irritable bowel syndrome: A placebo-controlled study of cisapride
    • Van Outryve M, Milo R, Toussaint J, Van Eeghem P. 'Prokinetic' treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol 1991; 13: 49-57.
    • (1991) J Clin Gastroenterol , vol.13 , pp. 49-57
    • Van Outryve, M.1    Milo, R.2    Toussaint, J.3    Van Eeghem, P.4
  • 77
    • 0030967149 scopus 로고    scopus 로고
    • Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome
    • Schutze K, Brandstatter G, Dragosics B, Judmaier G, Hentschel E. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 387-394.
    • (1997) Aliment Pharmacol Ther , vol.11 , pp. 387-394
    • Schutze, K.1    Brandstatter, G.2    Dragosics, B.3    Judmaier, G.4    Hentschel, E.5
  • 79
    • 0001525965 scopus 로고    scopus 로고
    • Investigations on a 5HT4 agonistt (SDZ HTF 919) and its main metabolite in conscious dogs: Effects on gastrointestinal motility and impaired gastric emptying
    • Fioramonti J, Million M, Bueno L. Investigations on a 5HT4 agonistt (SDZ HTF 919) and its main metabolite in conscious dogs: effects on gastrointestinal motility and impaired gastric emptying. Gastroenterology 2000; 114: A752.
    • (2000) Gastroenterology , vol.114
    • Fioramonti, J.1    Million, M.2    Bueno, L.3
  • 80
    • 0001394241 scopus 로고    scopus 로고
    • Effeects of tegaserod (HTF919) on gastrointtestinal motility and transit in awake rats
    • Huge A, Zittel TT, Kreis ME, Becker HD, Jehle EC. Effeects of tegaserod (HTF919) on gastrointtestinal motility and transit in awake rats. Gastroenterology 2000; 118: A403.
    • (2000) Gastroenterology , vol.118
    • Huge, A.1    Zittel, T.T.2    Kreis, M.E.3    Becker, H.D.4    Jehle, E.C.5
  • 81
    • 0031412762 scopus 로고    scopus 로고
    • Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit
    • Appel S, Kumle A, Meier R. Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit. Clin Pharmacol Ther 1997; 62: 546-555.
    • (1997) Clin Pharmacol Ther , vol.62 , pp. 546-555
    • Appel, S.1    Kumle, A.2    Meier, R.3
  • 82
    • 0034089045 scopus 로고    scopus 로고
    • Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome
    • Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000; 118: 463-468.
    • (2000) Gastroenterology , vol.118 , pp. 463-468
    • Prather, C.M.1    Camilleri, M.2    Zinsmeister, A.R.3    McKinzie, S.4    Thomforde, G.5
  • 83
    • 0003220750 scopus 로고    scopus 로고
    • Tegaserod, a partial 5-HT4 agonist improves abdominal discomfort/pain and altered bowel function in irritable bowel syndrome (IBS)
    • Schmitt C, Krumholz S, Tanghe J, Heggland J, Shi Y, Lefkowitz MP. Tegaserod, a partial 5-HT4 agonist improves abdominal discomfort/pain and altered bowel function in irritable bowel syndrome (IBS). Gut 1999; 45: A258.
    • (1999) Gut , vol.45
    • Schmitt, C.1    Krumholz, S.2    Tanghe, J.3    Heggland, J.4    Shi, Y.5    Lefkowitz, M.P.6
  • 84
    • 0001626523 scopus 로고    scopus 로고
    • 4 partial agonist, Tegaserod, improves abdominal bloating and altered stool consistency in irritable bowel syndrome (IBS)
    • 4 partial agonist, Tegaserod, improves abdominal bloating and altered stool consistency in irritable bowel syndrome (IBS). Gut 1999; 45: A260.
    • (1999) Gut , vol.45
    • Krumholz, S.1    Tanghe, J.2    Schmitt, C.3    Heggland, J.4    Shi, Y.5    Ruegg, P.6
  • 85
    • 0034794595 scopus 로고    scopus 로고
    • Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation
    • Mueller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001; 15: 1655-1666.
    • (2001) Aliment Pharmacol Ther , vol.15 , pp. 1655-1666
    • Mueller-Lissner, S.A.1    Fumagalli, I.2    Bardhan, K.D.3
  • 86
    • 0024427722 scopus 로고
    • Cisapride accelerates colonic transit in constipated patients with colonic inertia
    • Krevsky B, Maurer AH, Malmud LS, Fisher RS. Cisapride accelerates colonic transit in constipated patients with colonic inertia [see comments]. Am J Gastroenterol 1989; 84: 882-887.
    • (1989) Am J Gastroenterol , vol.84 , pp. 882-887
    • Krevsky, B.1    Maurer, A.H.2    Malmud, L.S.3    Fisher, R.S.4
  • 87
    • 0028801876 scopus 로고
    • The effect of cisapride on segmental colonic transit time in patients with spinal cord injury
    • Geders JM, Gaing A, Bauman WA, Korsten MA. The effect of cisapride on segmental colonic transit time in patients with spinal cord injury. Am J Gastroenterol 1995; 90: 285-289.
    • (1995) Am J Gastroenterol , vol.90 , pp. 285-289
    • Geders, J.M.1    Gaing, A.2    Bauman, W.A.3    Korsten, M.A.4
  • 88
    • 4243385591 scopus 로고    scopus 로고
    • Prucalopride (PRU) improves colonic transit and stool frequency in patients (PTS) with slow and normal transit constipation
    • Emmanuel AV, Nichols T, Roy AJ, Antonelli K, Kamm MA. Prucalopride (PRU) improves colonic transit and stool frequency in patients (PTS) with slow and normal transit constipation. Gastroenterology 2000; 118: A846.
    • (2000) Gastroenterology , vol.118
    • Emmanuel, A.V.1    Nichols, T.2    Roy, A.J.3    Antonelli, K.4    Kamm, M.A.5
  • 89
    • 0032754503 scopus 로고    scopus 로고
    • L-Type calcium channels in enterochromaffin cells from guinea pig and human duodenal crypts: An in situ study
    • Lomax RB, Gallego S, Novalbos J, Garcia AG, Warhurst G. L-Type calcium channels in enterochromaffin cells from guinea pig and human duodenal crypts: an in situ study. Gastroenterology 1999; 117: 1363-1369.
    • (1999) Gastroenterology , vol.117 , pp. 1363-1369
    • Lomax, R.B.1    Gallego, S.2    Novalbos, J.3    Garcia, A.G.4    Warhurst, G.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.